Company intelligence / Profile preview
Anavex Life Sciences Corp.
New York, NY, USAanavex.com ↗
- Ownership
- Public · AVXL
- Employees
- ~60
- Development stage
- Other
01
Overview
Anavex's lead candidate, ANAVEX®2‑73 (blarcamesine), has shown positive results in a Phase IIb/III open-label extension trial for early Alzheimer’s disease, demonstrating significant reduction in clinical decline over three years of continuous treatment. In Rett syndrome pediatric studies, the drug showed improvement but did not reach statistical significance on all primary endpoints; however, adult studies have shown statistically significant reductions in severity. The company is also advancing ANAVEX®3‑71 into Phase 2 trials for schizophrenia and other CNS indications
- Therapeutic areas
- PsychiatryNeurology
- Modalities
- Small molecules (orally available)
- Industry
- Biotech
02
Drug pipeline
7 assets6 more assets in the full pipeline.
03
Partnerships
The Michael J. Fox Foundation
04
Financials
- Market cap
- $102.9M
- Total revenue
- $0
- Enterprise value
- $-15.4M
Beyond the preview
Go deeper on Anavex Life Sciences Corp..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Anavex Life Sciences Corp..